Results 91 to 100 of about 12,259 (202)

Stimulation of "regulatory" dopamine receptors by bromocriptine (CB-154).

open access: yes, 1978
Bromocriptine produces long-lasting hypomotility and decreases brain dihydroxyphenylacetic acid (DOPAC) in mice. These effects are obtained with doses much lower than those which produce hypermotility.
DI CHIARA, GAETANO   +3 more
core   +1 more source

The effects of vaginal bromocriptine and dienogest on women with adenomyosis: a clinical study

open access: yesMiddle East Fertility Society Journal
Objective Adenomyosis occurs when endometrial glands and stroma develop in the myometrium, leading to symptoms such as pelvic pain and heavy menstrual bleeding. Method This randomized, double-blinded, controlled trial study was conducted on patients with
Parvane Bahoorzahi   +4 more
doaj   +1 more source

Bromocriptine treatment of the premenstrual syndrome

open access: yes, 1987
Bu çalışma, 19 Nisan 1983 tarihinde Bursa[Türkiye]'de düzenlenen Prolaktin ve Sterilite Tedavisi Sempozyumunda bildiri olarak sunulmuştur.Çalışmamızda premenstrual sendromlu (PMS) 28 kadında ve kontrol grubu olarak hiçbir şikayeti olmayan 10 kadında ...
Şahmay, Sezai   +3 more
core  

Surgical Management of Gestational Gigantomastia: A Case Report Highlighting Therapeutic Intervention

open access: yesPlastic and Reconstructive Surgery, Global Open
Summary:. Gigantomastia is an exceedingly rare condition characterized by extraordinary growth of breasts during pregnancy, and its underlying etiology remains elusive.
Misha A. Lemma, MD   +4 more
doaj   +1 more source

Bromocriptine is ineffective in the treatment of chronic nonfluent aphasia

open access: yes, 1995
The effect of bromocriptine on chronic nonfluent aphasia was investigated in 4 patients suffering from a stroke 24 to 35 months before the onset of this study (average 29 months).
Ozeren A.   +3 more
core   +1 more source

Treatment of patients with prolactinomas [PDF]

open access: yes, 1978
Fahlbusch, R.   +5 more
core   +1 more source

Severe leukopenia and mild thrombocytopenia after chronic bromocriptine (CB-154) administration

open access: yes, 1981
A 23-year-old woman was receiving bromocriptine (CB-154, 7.5-10 mg/day, for a hyperprolactinemic galactorrhea-amenorrhea syndrome. She also had insulin-dependent diabetes.
FERDEGHINI, Marco   +2 more
core   +1 more source

Home - About - Disclaimer - Privacy